N/A
Completed N=24
Macrolane for Enhancement of the Shape and Fullness of the Female Breast
Breast Enhancement
Source: ClinicalTrials.gov NCT01308853 ↗
Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcomePrimary: Number of Breasts With Successful Placement of the Implant Posterior to the Mammary Gland at 6 Weeks After Treatment — 48 Breasts
Summary
The study evaluates treatment procedure, efficacy and safety of Macrolane for female breast enhancement.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Breasts With Successful Placement of the Implant Posterior to the Mammary Gland at 6 Weeks After Treatment |
48 | — |
| SECONDARY Percentage of Breasts With Improvement as Assessed by the Investigator |
100 | — |
Eligibility Criteria
Inclusion Criteria
- Female between 25 and 50 years of age with small breasts seeking enhancement of the shape and fullness of the breast
Exclusion Criteria
- Unreasonable expectations
- Any medical condition that may interfere with the treatment
Data sourced from ClinicalTrials.gov (NCT01308853). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.